This charter aims to regulate the rights, duties, responsibilities, and other necessary matters between the Company and its Members in connection with the use of the AI-based fundus image interpretation solution and related services provided by CRYSTAR VISION.

A Member refers to a person who agrees to this charter and enters into a service agreement with the Company.

A Medical Institution Member refers to the owner or a licensed medical professional of a medical institution who uses the Company’s services. This includes hospitals, clinics, doctors, nurses, and other qualified medical personnel.

A Corporate Member refers to a business entity engaged in medical-related industries, including medical device manufacturers and pharmaceutical companies, that uses the Company’s services.

A General Member refers to a member who does not fall under the categories of Medical Institution Member or Corporate Member and who uses portions of the service that are available for general users, where applicable.

Membership registration is completed when a person wishing to use the service agrees to this charter and submits the required information through the online registration form designated by the Company.

Medical Institution Members are required to submit documents such as a medical institution registration certificate or a medical license in the manner specified by the Company.

Corporate Members are required to submit documents such as a business registration certificate and other relevant permits in the manner specified by the Company.

The Company may conduct additional verification procedures when necessary and may request the submission of supplementary materials from the Member.

Members must notify the Company of any changes to the information provided at the time of registration within seven days from the date of such change or within a period designated by the Company, or must directly update the information through the member information modification page.

The Company shall not be responsible for any disadvantages resulting from delays in updating member information, and all related responsibility shall rest with the Member.

The Company provides services including AI-based fundus image interpretation, medical data analysis, and platform-based services related to medical image and data sharing and system integration.

All AI analysis results provided by the Company are intended solely as reference materials to assist medical judgment. Final medical judgment and responsibility lie exclusively with qualified medical professionals such as Medical Institution Members. The Company does not assume liability for medical judgments made in connection with the use of the service.

The service is generally available at all times throughout the year. However, service availability may be temporarily restricted due to regular maintenance or technical reasons, and the Company will make reasonable efforts to provide advance notice in such cases.

Service fees are determined according to the pricing system established by the Company, and detailed fee information is provided in advance through the website, electronic communications, or written notices depending on service type, usage method, and member category.

Members are required to pay service fees in accordance with the payment method specified by the Company. Failure to make timely payment may result in restrictions on service usage.

Matters related to refunds, cancellations, or changes to service fees are governed by the Company’s refund policy, which will be communicated separately.

The Company makes efforts to protect Members’ personal information in accordance with applicable laws, including the Personal Information Protection Act and the Information and Communications Network Act.

The collection, handling, and protection of personal information are governed by the Company’s Privacy Policy, and Members are deemed to have agreed to such policy upon registration.

The Company and Members must comply with applicable laws, including the Medical Act and the Personal Information Protection Act, as well as relevant medical information protection guidelines when processing and safeguarding medical information.

Medical Institution Members must not provide or disclose medical information to third parties. In the event of a data breach or leakage, the matter must be reported to the Company without delay.

The Company shall not use medical information provided by Members for purposes other than service provision and shall not disclose such information to third parties without the Member’s consent, unless otherwise required by law.

Members may terminate the service agreement at any time through the withdrawal procedure. Upon withdrawal, personal information will be handled in accordance with applicable laws and the Company’s Privacy Policy.

The Company may restrict service usage if circumstances arise that violate this charter or applicable laws. Prior notice will generally be provided, except in urgent cases where immediate action is required, in which case notice will be given afterward.

Members whose service usage has been restricted may submit an appeal in accordance with the procedures established by the Company. If the appeal is determined to be justified, service usage will be restored without delay.

The Company may amend this charter when deemed necessary, provided that such amendments do not violate applicable laws.

In the event of an amendment, the Company will notify Members of the effective date and the reasons for the amendment in advance. Notice will be provided at least seven days prior to the effective date, or thirty days prior in the case of significant changes.

Members who do not expressly object to the amended charter before its effective date shall be deemed to have agreed to the amendment.

The Company and Members shall make good faith efforts to resolve any disputes arising in connection with the use of the service.

If a dispute cannot be resolved through mutual consultation, it shall be governed by the laws of the Republic of Korea, and the court having jurisdiction over the Company’s principal place of business shall have exclusive jurisdiction.